Institute for Clinical and Experimental Medicine is the largest Czech medical research and clinical hospital located in Prague–Krč. It is directly managed the Ministry of Health and it was established in 1971 as a part of nearby Thomayer Hospital.

There are 312 (2020) beds in Institute for Clinical and Experimental Medicine.

During the past decade, Institute for Clinical and Experimental Medicine conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 15 clinical trials were completed, i.e. on average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 8 clinical trials were completed. i.e. 29.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute for Clinical and Experimental Medicine" #1 sponsor was "Institute for Clinical and Experimental Medicine" with 33 trials, followed by "Abbott Medical Devices" with 8 trials sponsored, "Biotronik SE & Co. KG" with 8 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Biosense Webster, Inc." with 4 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Clinical and Experimental Medicine" #1 collaborator was "Thoratec Corporation" with 4 trials as a collaborator, "Charles University, Czech Republic" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 2 trials as a collaborator and "Institute for Clinical and Experimental Medicine" with 2 trials as a collaborator. Other collaborators include 78 different institutions and companies that were collaborators in the rest 86 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Clinical and Experimental Medicine" are "Atrial Fibrillation" (14 trials), "Heart Failure" (8 trials), "Ventricular Tachycardia" (5 trials), "Diabetes Mellitus, Type 2" (4 trials) and "Insulin Resistance" (3 trials). Many other conditions were trialed in "Institute for Clinical and Experimental Medicine" in a lesser frequency.

Most popular intervention types in "Institute for Clinical and Experimental Medicine" are "Device" (30 trials), "Drug" (29 trials), "Other" (20 trials), "Procedure" (20 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apixaban" (2 trials), "HeartMate 3" (2 trials), "Warfarin" (2 trials) and "25g Ketone monoester without added salts" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Clinical and Experimental Medicine" are 93 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 32 active trials in "Institute for Clinical and Experimental Medicine". 2 are not yet recruiting, 22 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 51 completed trials in Institute for Clinical and Experimental Medicine, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Clinical and Experimental Medicine, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 44 trials that are defined as “Not Applicable".

Institute for Clinical and Experimental Medicine has several departments that took part in Clinical trials: "Klinika Kardiologie IKEM" - 2 trials